Honeywell International’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-103,530
Closed -$17.3M 155
2018
Q2
$17.3M Sell
103,530
-46,000
-31% -$7.38M 1.04% 32
2018
Q1
$25.2M Sell
149,530
-92,800
-38% -$15.6M 1.47% 14
2017
Q4
$39.6M Buy
242,330
+100
+0% +$17.9K 1.31% 20
2017
Q3
$49.6M Buy
242,230
+74,100
+44% +$17.2M 1.74% 14
2017
Q2
$40.9M Buy
168,130
+20,100
+14% +$4.72M 1.54% 12
2017
Q1
$35.4M Sell
148,030
-48,500
-25% -$11.3M 1.14% 21
2016
Q4
$41.3M Buy
196,530
+17,100
+10% +$3.54M 1.38% 16
2016
Q3
$41.3M Sell
179,430
-72,000
-29% -$17.6M 1.44% 14
2016
Q2
$58.1M Buy
251,430
+85,700
+52% +$19.8M 1.48% 11
2016
Q1
$44.4M Buy
165,730
+24,000
+17% +$6.87M 1.12% 23
2015
Q4
$44.3M Buy
+141,730
New +$42.2M 1.12% 20

Other funds holding AGN

Honeywell International's AGN Position: Q3 2018 in Review

Honeywell International sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 103,530 shares — an estimated $17.3M sold.

Honeywell International first reported a position in AGN in Q4 2015 and held it in 11 quarters. The position peaked at $58.1M in Q2 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Honeywell International reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Honeywell International sold 103,530 Allergan plc shares in Q3 2018, an estimated $17.3M.
  • Honeywell International first reported a position in Allergan plc in Q4 2015 and held it in 11 quarters.
  • Honeywell International's Allergan plc position peaked at $58.1M in Q2 2016.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Honeywell International's 13F filing for Q3 2018, filed 7 Nov 2018.